Journal Home
Search for

Volume 20, Issue 6, Pages 386-393 (July 2010)


View previous. 4 of 15 View next.

Cardiovascular diseases in American women

Y. ZhangCorresponding Author Informationemail address

Received 12 June 2009; received in revised form 11 December 2009; accepted 1 February 2010. published online 31 May 2010.

Abstract 

Aims

Cardiovascular disease (CVD) is one of the major public health issues in women among diverse populations across the world. This article reports current information about the occurrence and risk factors of atherosclerotic CVD in American women.

Data Synthesis

The most recent scientific publications from the American Heart Association, the Centers for Disease Control and Prevention, and the National Heart, Lung, and Blood Institute and elsewhere were reviewed with regard to CVD in the US population. We focussed on the atherosclerotic CVD in women, which includes coronary heart disease, stroke and heart failure. Prevalence, incidence and mortality of these diseases in women were described. The statistics about CVD on women were compared to men's. Special physiological changes in women and their relationships to CVD were discussed. The major modifiable risk factors were discussed.

Conclusion

About 35% women in the United States have some form of CVD and for men, this number is 37.6%. The CVD incidence for women was close to that of men 10 years younger. The gap narrows with advancing age. Since 1984, the number of CVD deaths for women has exceeded those for men. Women represent 52.6% of CVD deaths, and CVD is the leading cause of death in US women. In both men and women risk factors such as hypertension, high blood cholesterol level, smoking, lack of physical activity and obesity increase the probability of developing CVD. Menopause, oral contraceptive use and bilateral oophorectomy in premenopausal women also affect the risk of CVD in women.

Center for American Indian Health Research, College of Public Health, University of Oklahoma Health Sciences Center, P. O. Box 26901, Oklahoma City, OK 73190, USA

Corresponding Author InformationTel.: +1 405 271 3090x46720; fax: +1 405 271 4390.

PII: S0939-4753(10)00036-0

doi:10.1016/j.numecd.2010.02.001


View previous. 4 of 15 View next.